Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Account Payables (2020 - 2025)

Celularity has reported Change in Account Payables over the past 6 years, most recently at $187000.0 for Q3 2025.

  • Quarterly results put Change in Account Payables at $187000.0 for Q3 2025, down 89.06% from a year ago — trailing twelve months through Sep 2025 was $9.2 million (up 201.73% YoY), and the annual figure for FY2024 was $9.2 million, up 8.73%.
  • Change in Account Payables for Q3 2025 was $187000.0 at Celularity, down from $1.1 million in the prior quarter.
  • Over the last five years, Change in Account Payables for CELU hit a ceiling of $7.9 million in Q4 2024 and a floor of -$3.2 million in Q4 2022.
  • Median Change in Account Payables over the past 5 years was $775000.0 (2024), compared with a mean of $1.0 million.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 2033.77% in 2021 and later crashed 297.5% in 2022.
  • Celularity's Change in Account Payables stood at $1.6 million in 2021, then crashed by 297.5% to -$3.2 million in 2022, then skyrocketed by 153.71% to $1.7 million in 2023, then skyrocketed by 354.79% to $7.9 million in 2024, then tumbled by 97.64% to $187000.0 in 2025.
  • The last three reported values for Change in Account Payables were $187000.0 (Q3 2025), $1.1 million (Q2 2025), and $17000.0 (Q1 2025) per Business Quant data.